Cargando…
The Pharmacology, Efficacy, and Safety of Rivaroxaban in Obese Patient Populations
Cardiovascular disease (CVD) remains the leading cause of death in the USA. Several risk factors have been identified, and obesity has become one of prominent concern. Excessive weight is considered a risk factor for CVD based on evidence linking it to a hypercoagulable state. Considering the preval...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089078/ https://www.ncbi.nlm.nih.gov/pubmed/32803514 http://dx.doi.org/10.1007/s40256-020-00434-w |